Cancer of the oral cavity

Current Problems in Surgery

Volumn 37, Issue 10, 2000, Pages 633-731

  Chen, Amy Y ^a   Myers, Jeffrey N ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; CELL TRANSFORMATION; DIAGNOSTIC IMAGING; DISEASE COURSE; GENETIC PREDISPOSITION; GENETICS; HUMAN; LYMPHADENECTOMY; MOUTH TUMOR; PATHOLOGY; POSTOPERATIVE COMPLICATION; REVIEW; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPH NODE EXCISION; MOUTH NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RADIOTHERAPY, ADJUVANT;

EID: 0034296709     PISSN: 00113840     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0011-3840(00)80004-0     Document Type: Article

References (239)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer Statistics, 2000. CA Cancer J Clin 2000:50:7-33.
2. Patterns of cancer in five continents. IARC Sei Publ 1990; 102:1 -160.
3. Lydia DD, Robbins KT, Byers RM, Wolf PF. Treatment of stage I and II oral tongue cancer. Head Neck 1993:15:308-12.
4. Rodgers LW Jr, Stringer SP, Mendenhall WM, Parsons JT, Cassisi NJ, Million RR. Management of squamous cell carcinoma of the floor of the mouth. Head Neck 1993:15:16-9.
5. Shaha AR, Spiro RH, Shah JP, Strong EW. Squamous carcinoma of the floor of the mouth. Am J Surg 1984:148:455-9.
6. Kowalski LP, Hashimoto I, Magrin J. End Results of 114 extended "commando" operations for retromolar trigone carcinoma. Am J Surg 1993;166:374-9.
7. Byers RM, Anderson B, Schwarz EA. Fields RS, Meoz R. Treatment of squamous carcinoma of the retromolar trigone. Am J Clin Oncol 1984:7:647-52.
8. Byers RM, Newman R, Russell N, Yue A. Results of treatment for squamous carcinoma of the lower gum. Cancer 1981:47:2236-8.
9. Eicher SA, Overholt SM. El Naggar AK, Byers RM, Weber RS. Lower gingival carcinoma: clinical and pathologic determinants of regional métastases. Arch Otolaryngol Head Neck Surg 1996:122:634-8.
10. Overholt SM. Eicher SA, Wolf R Weber RS. Prognostic factors affecting outcome in lower gingival carcinoma. Laryngoscope 1996:106:1335-9.
11. Soo KC. Spiro RH. King W, Harvey W, Strong EW. Squamous carcinoma of the gums. Am J Surg 1988:156:281-5.
12. Chung CK, Johns ME, Cantrell RW, Constable WC. Radiotherapy in the management of primary malignancies of the hard palate. Laryngoscope 1980;90:576-84.
13. Prokopakis EP, Snyderman CH, Hanna EY, Carrau RL, Johnson JT, D'Amico F. Risk factors for local recurrence of adenoid cystic carcinoma: the role of postoperative radiation therapy. Am J Otolaryngol 1999:20:281-6.
14. Fordice J, Kershaw C. El Naggar A, Goepfert H. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 1999:125:149-52.
15. Anderson JN Jr, Beenken SW, Crowe R, Soong SJ. Peters G, Maddox WA. et al. Prognostic factors in minor salivary gland cancer. Head Neck 1995:17:480-6.
16. Mishra RC, Parida G, Mishra TK, Mohanty S. Tumour thickness and relationship to locoregional failure in cancer of the buccal mucosa. Eur J Surg Oncol 1999:25:186-9.
17. Strome SE. To W, Strawderman M. et al. Squamous cell carcinoma of the buccal mucosa. Otolaryngol Head Neck Surg 1999:120:375-9.
18. Brizel DM, Albers ME. Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998:338:1798-804.
19. Nowell PC. The clonal evolution of tumor cell populations. Science 1976:194:238.
20. Fearon ER. Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990:6:759-67.
21. Hahn WC, Counter C M. Lundberg AS, Beijersbergen RL. Brooks MW. Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 1999:400:464-8.
22. Hanahan D. Weinberg RA. The hallmarks of cancer. Cell 2000:100:57-70.
23. Downward J. Yarden Y, Mayes E. et al. Close similarity of epidermal growth factor receptor gene and v-erb-B oncogene protein sequences. Nature 1984:307:521-7.
24. Grandis JR. Tweardy D. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993:53:3579-84.
25. Grandis JR. Meinem MF, Gooding WE. et al. Levels of TGF-cc and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 1998:90:824-32.
26. Papadimitrakopoulou V. Izzo J. Lippman SM, et al. Frequent inactivation of p 16mk4;l in oral premalignant lesions. Oncogene 1997:14:1799-803.
27. El-Naggar A. Lai S, Clayman GE. et al. Expression of p!6, Rb, and cyclin Dl gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. Hum Pathol 1999:30:1013-8.
28. Mao L. Lee JS, Fan YH. et ai. Frequent microsatellite alterations at chromosomes 9p21 and 3pl4 in oral premalignant lesions and their value in cancer risk assessment. Nat Med 1996:2:682-5.
29. Bova RJ. Quinn Dl, Nankervis JS, et al. Cyclin Dl and p!6INK4A expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 1999:5:2810-9.
30. Yao L. Iwai M, Furuta I. Correlations of bcl-2 and p53 expression with the cltnicopathological features in tongue squamous cell carcinomas. Oral Oncol 1999:35:5662.
31. Liu TJ, El-Naggar AK, McDonnell TJ. et al. Apoptosis induction mediated by wildtype p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck. Cancer Res 1995:55:3117-22.
32. Liu TJ, Zhang WW, Taylor DL, Roth JA, Goepfert H. Clayman GL. Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 1994:54:3662-7.
33. Clayman GL, El-Naggar AK, Lippman SM, et al. Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol 1998:16:2221-32.
34. Xie X. Clausen OP. De Angelis P, Boy sen M. The prognostic value of spontaneous apoptosis. Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer 1999:86:913-20.
35. Mao L. El-Naggar AK, Fan YH. et al. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res 1996:56:5600-4.
36. Fidler U, Kumar R, Bielenberg DR, Ellis LM. Molecular determinants of angiogenesis in cancer metastasis. Cancer J Sei Am 1998;4:S58-66.
37. Shpitzer T, Chaimaoff M, Gal R, Stern Y, Feinmesser R, Segal K. Tumor angiogenesis as a prognostic factor in early oral tongue cancer. Arch Otolaryngol Head NeckSurg 1996:122:865-8.
38. Zatterstrom K, Brun E, Willen R, Kjellen E, Wennerberg J. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head Neck 1995:17:312-8.
39. Dray TO. Hardin NJ, Sofferman RA. Angiogenesis as a prognostic marker in early head and neck cancer. Ann Otol Rhinol Laryngol 1995:104:724-9.
40. Gleich LL. Biddinger PW, Pavelic ZP, Gluckman JL. Tumor angiogenesis in Tl oral cavity squamous cell carcinoma: role in predicting tumor aggressiveness. Head Neck 1996:18:343-6.
41. Moriyama M. Kumagai S, Kawashiri S, Kojima K, Kakihara K, Yamamoto E. Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma. Oral Oncol 1997:33:369-74.
42. Denhart BC. Guidi AJ, Tognazzi K, Dvorak H. Brown LF. Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous cell carcinoma and dysplasia. Lab Invest 1997:77:659-64.
43. Sahen P. Heikkila P. Anttonen A, Kajanti M, Joensuu H. Vascular endothelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 1997:10:1128-33.
44. Myoken Y. Okamoto T. Sato JD, Takada K. Immunocytochemical localization of fibroblast growth factor-1 (FGF-1) and FGF-2 in oral squamous cell carcinoma (SCC). J Oral Pathol Med 1994:23:451-6.
45. Janot F. El-Naggar AK, Morrison RS. Liu TJ, Taylor DL. dayman GL. Expression of basic fibroblast growth factor in squamous cell carcinoma of the head and neck is associated with degree of histologie differentiation. Int J Cancer 1995:64:117-23.
46. Fujieda S. Sunaga H. Tsuzuki H, Tanaka N, Saito H. Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma. Clin Cancer Res 1998:4:1583-90.
47. Cohen RF. Contrino J, Spiro JD, Mann EA, Chen LL, Kreutzer DL. Interleukin-8 expression by head and neck squamous cell carcinoma. Arch Otolaryngol Head NeckSurg 1995:121:202-9.
48. Richards BL. Eisma RJ, Spiro JD, Lindquist RL, Kreutzer DL. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am J Surg 1997:174:507-12.
49. Liotta L. Tumor invasion and metastasis: role of the extracellular matrix. Cancer Res 1986:46:1-7.
50. Sutinen M, Kainulainen T, Hurskainen T, et al. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and-3) in oral lichen planus. dysplasia, squamous cell carcinoma and lymph node metastasis. Br J Cancer 1998:12:2239-45.
51. Kusukawa J, Sasaguri Y, Shima I, Kameyama T, Morimatsu M. Expression of matrix metalloproteinase-2 related to lymph node metastasis of oral squamous cell carcinoma: a clinicopathologic study. Am J Clin Pathol 1993:99:18-23.
52. Nozaki S, Endo Y, Kawashiri S, et al. immunohistochemical localization of a urokinasetype plasminogen activator system in squamous cell carcinoma of the oral cavity: association with mode of invasion and lymph node metastasis. Oral Oncol 1998:34:58-62.
53. Arbes SJ Jr. Olshan AF. Caplan DJ. Schoenbach VJ. Slade GD. Symons MJ. Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States). Cancer Causes Control 1999;10:513-23.
54. Caplan DJ, Hertz-Picciotto I. Racial differences in survival of oral and pharyngeal cancer patients in North Carolina. J Public Health Dent 1998:58:36-43.
55. Barasch A, Morse DE, Krutchkoff DJ. Eisenberg E. Smoking, gender, and age as risk factors for site-specific intraoral squamous cell carcinoma: a case-series analysis. Cancer 1994;73:509-13.
56. Rubright WC. Huffman HT, Lynch CF, et al. Risk factors for advanced-stage oral cavity cancer. Arch Otolaryngol Head Neck Surg 1996:122:621-6.
57. Li FP. Inherited susceptibility to cancer [abstract]. Proc Am Assoc Cancer Res 1995:36:648.
58. Wang LE. Sturgis EM, Eicher SA, Spitz MR, Hong WK, Wei, Q. Mutagen sensitivity to benzo(a)pyrene diol epoxide and the risk of squamous cell carcinoma of the head and neck. Clin Cancer Res 1998:4:1773-8.
59. Sturgis EM. Castillo EJ, Li L. et al. Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 1999;20:2125-9.
60. Spitz MR, Wu X, Jiang H. Hsu TC. Mutagen sensitivity as a marker of cancer susceptibility. J Cell Biochem Suppl 1996;25:80-4.
61. Spitz MR. Wei Q. Li G. Wu X. Genetic susceptibility to tobacco carcinogenesis. Cancer Invest 1999; 17:645-59.
62. Lippman SM, Spitz MR. Huber MH, Hong WK. Strategies for chemoprevention study of premalignancy and second primary tumors in the head and neck. Curr Opin Oncol 1995;7:234-41.
63. Cheng L, Sturgis EM, Eicher SA, Char D, Spitz MR, Wei Q. Glutathione-S-transferase polymorphisms and risk of squamous-cell carcinoma of the head and neck. IntJ Cancer 1999:84:220-4.
64. Adams V, Schmid S, Zariwala M, et al. Prevalence of human papilloma virus DNA in head and neck cancers carrying wild-type or mutant P53 tumor suppressor genes. Anticancer Res 1999:19:1-6.
65. Haraf DJ, Nodzenski E, Brachman D, et al. Human Papilloma virus and P53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996:2:755-62.
66. Pearson GR. Epstein-Barr virus and nasopharyngeal carcinoma. J Cell Biochem Suppl 1993 ;17F: 150-4.
67. Mills CA, Porter MM. Tobacco smoking habits and cancer of the mouth and respiratory system. Cancer Res 1950; 10:539-42.
68. Rothman KJ, Keller AZ. The effect of joint exposure to alcohol and tobacco on the risk of cancer of the mouth and pharynx. J Chronic Dis 1972:25:711-6.
69. Winn DM. Smokeless tobacco and cancer: the epidemiologic evidence. CA Cancer J Clin 1988:38:236-43.
70. Jusawalla DJ, Despandi VA. Evaluation of cancer risk in tobacco chewers and smokers: an epidemiologic assessment. Cancer 1971;28:244-52.
71. Phillips RL, Garfunkel L, Kuzman JW. Mortality among Californian Seventh-Day Adventists for selected cancer sites. J Natl Cancer Inst 1980:65:1097-103.
72. Larsson LG, Sandstrom A, Westling P. Relationship of Plummer-Vinson disease to cancer of the upper alimentary tract in Sweden. Cancer Res 1975:35:3308-16.
73. Glynn TJ, Manley MW. How to help your patients stop smoking: a National Cancer Institute Manual for physicians. Washington. DC: U.S. Department of Health and Human Services; 1990.
74. Mao L, El Naggar AK, Fan YH, et al. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res 1996:56:5600-4.
75. Slaughter DP. Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium. Cancer 1953:6:963-8.
76. Hong WK, Endicott J, Itri LM, et al. 13-Cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986;315:1501-5.
77. Lippman SM, Heyman RA, Kurie JM, Benner SE, Hong WK. Retinoids and chemoprevention: clinical and basic studies. J Cell Biochem Suppl 1995:22:1-10.
78. Benner SE, Winn RJ, Lippman SM, et al. Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study. J Natl Cancer Inst 1993:85:44-7.
79. Alvi A. Myers EN, Johnson JT. Cancer of the oral cavity. In: Myers EN, Suen JY, editors. Cancer of the head and neck. 3rd edition. Philadelphia: Mosby; 1996. p.321-60.
80. Kannan S. Balaram P, Pillai MR. Ultrastructural variations and assessment of malignant transformation risk in oral leukoplakia. Pathol Res Pract 1993:189:116-980.
81. Silverman S, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation: a follow-up study. Cancer 1984;53:563-8.
82. Kramer IRH, El-Lablan D, Lee KW. The clinical features and risk of malignant transformation in sublingual keratosis. Br Dent J 1978:144:171-80.
83. Vas'Kovaskaia GP, Abramova El. Cancer development from lichen planus on the oral and labial mucosa. Stomatologiia (Mosk) 1981;40:46-8.
84. Spiro RH, Huvos AG, Wong GY, Spiro JD. Gnecco CA, Strong EW. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 1986:152:345-50.
85. Broders AC. Squamous cell epithelioma of the lip. JAMA 1920:74:656-64.
86. Anneroth G, Batsakis J, Luna M. Review of the literature and a recommended system of malignancy grading in oral squamous cell carcinomas. Scand J Dent Res 1987:95:229-49.
87. Soo KC, Carter RC, O'Brien CJ, Barr L, Bliss JM, Shaw. HJ. Prognostic implication of perineural spread in squamous carcinomas of the head and neck. Laryngoscope 1986;96:l 145-8.
88. Borges AM, Shrikhande SS, Ganesh, B. Surgical pathology of squamous carcinoma of the oral cavity: its impact on management. Semin Surg Oncol 1989:5:310-7.
89. Pagan JJ. Collins B, Barnes L, D'Amico F, Myers EN, Johnson JT. Perineural invasion in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1998:124:637-40.
90. Martinez-Gimeno C, Rodriguez EM, Vila CN, Varela CL. Squamous cell carcinoma of the oral cavity: a clinicopathologic scoring system for evaluating risk of cervical lymph node metastasis. Laryngoscope 1995:105:728-33.
91. Close LG, Burns DK, Reisch J, Schaefer SD. Microvascular invasion in cancer of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 1987:113:1191-5.
92. Byers RM, Bland KI, Borlase B, Luna M. The prognostic and therapeutic value of frozen section determinations in the surgical treatment of squamous carcinoma of the head and neck. Am J Surg 1978:136:525-8.
93. Spiro RH, Guillamondegui O Jr. Paulino AF, Huvos AG. Pattern of invasion and margin assessment in patients with oral tongue cancer. Head Neck 1999:21:408-13.
94. Winzenburg SM, Niehans GA. George E. Daly K. Adams GL. Basaloid squamous carcinoma: a clinical comparison of two histologie types with poorly differentiated squamous cell carcinoma. Otolaryngol Head Neck Surg 1998:119:471-5.
95. Ackerman LV. Verrucous carcinoma of the oral cavity. Surgery 1948:23:670-8.
96. Spiro RH. Verrucous carcinoma, then and now. Am J Surg 1998:176:393-7.
97. Shear M. Pindborg J.I. Verrucous hyperplasia of the oral mucosa. Cancer 1980:46:1855-62.
98. Batsakis JG. Hybels R, Crissman JD. Rice DH. The pathology of head and neck tumors: verrucous carcinoma, part 15. Head Neck Surg 1982:5:29-38.
99. Batsakis J. Pathology of tumors of the oral cavity. In: Thawley S, Panje WR, Batsakis J, Lindberg RD, editors. Comprehensive management of head and neck tumors. 2nd edition. Philadelphia: Saunders: 1999. p.632-72.
100. Ellis GL, Corio RL. Spindle cell carcinoma of the oral cavity: a clinicopathologic assessment of fifty-nine cases. Oral Surg 1980:50:523-30.
101. Smyth AG, Ward-Booth RP. Avery BS. To EW. Malignant melanoma of the oral cavity: An increasing clinical diagnosis? Br J Oral Maxillofac Surg 1993:31:230-5.
102. Jindal JR, Campbell BH, Ward TO, Almagro US. Kaposi's sarcoma of the oral cavity in a non-AIDS patient: case report and review of the literature. Head Neck 1995:17:64-8.
103. Freeman C. Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972:29:252-60.
104. Weber RS. Palmer JM, El Naggar A. Minor salivary gland tumors of the lip and buccal mucosa. Laryngoscope 1989:99:6-9.
105. Beckhardt RN, Weber RS, Zane R. et al. Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome. Laryngoscope 1995:105: 1155-60.
106. van der Wal JE, Snow GB, van der waal I. Intraoral adenoid cystic carcinoma: the presence of perineural spread in relation to site, size, local extension, and metastatic spread in 22 cases. Cancer 1990:66:2031-3.
107. Spiro RH, Koss LG, Hajdu SI, Strong EW. Tumors of minor salivary origin: a clinicopathologic study of 492 cases. Cancer 1973:31:117-29.
108. Garden AS, Weber RS. Ang KK, Morrison WH, Matre J, Peters LJ. Postoperative Radiation therapy for malignant tumors of minor salivary glands: outcome and patterns of failure. Cancer 1994:73:2563-9.
109. Krolls SO, Hoffman S. Squamous cell carcinoma of the oral soft tissues: a statistical analysis of 14,253 cases by age. sex, and race of patients. J Am Dent Assoc 1976:92:571-4.
110. Frazell EL, Lucas JC. Cancer of the tongue: report of the management of 1554 patients. Cancer 1962:15:1085-9.
111. Robbins KT, Medina JE, Wolf GT, Levine P, Sessions R, Pruet C. Standardizing neck dissection terminology. Arch Otolaryngol 1991;! 17:601-5.
112. Byers RM. Modified neck dissection: a study of 967 cases from 1970 to 1980. Am J Surg 1985:150:414-21.
113. Lindberg RD. Distribution of cervical lymph node métastases from squamous cell cancer of the upper respiratory and digestive tracts. Cancer 1972;29:1446-9.
114. American Joint Committee for Cancer Staging and End-Results Reporting. Chicago: American Joint Committee on Cancer; 1998.
115. Pugliano FA, Piccirillo JF, Zequeira MR, Fredrickson JM, Ferez ÇA, Simpson JR. Clinical-severity staging system for oral cavity cancer: five-year survival rates. Otolaryngol Head Neck Surg 1999:120:38-45.
116. Johnson JT, Myers EN, Bedetti CD, Barnes EL, Schramm VL Jr. Thearle PB. Cervical lymph node métastases: incidence and implications of extracapsular carcinoma. Arch Otolaryngol 1985;! 11:534-7.
117. Snow GB. Annyas AA, van Slooten EA, Bartelink H. Hart AA. Prognostic factors of neck node metastasis. Clin Otolaryngol 1982:7:185-92.
118. Woolgar JA, Rogers S, West CR, Errington RD. Brown JS, Vaughan ED. Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. Oral Oncol 1999:35:257-65.
119. Houghton DJ. Hughes ML. Garvey C. et al. Role of chest CT scanning in the management of patients presenting with head and neck cancer. Head Neck 1998:20:614-8.
120. Ginsberg LE, DeMonte F. Imaging of perineural tumor spread from palatal carcinoma. AJNR Am J Neuroradiol 1998; 19:1417-22.
121. Caldemeyer KS, Mathews VP, Righi PD, Smith RR. Imaging features and clinical significance of perineural spread or extension of head and neck tumors. Radiographies 1998:18:97-110.
122. van den Brekel MW. Reitsma LC, Quak JJ, et al. Sonographically guided aspiration cytology of neck nodes for selection of treatment and follow-up in patients with NO head and neck cancer. AJNR Am J Neuroradiol 1999:20:172-731.
123. van den Brekel MW, Castelijns JA, Reitsma LC, Leemans CR, van der Waal I, Snow GB. Outcome of observing the NO neck using ultrasonographic-guided cytology for follow-up. Arch Otolaryngol Head Neck Surg 1999:125:153-6.
124. van den Brekel MW. Castelijns JA, Stel HV, Golding RP, Meyer CJ, Snow GB. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node métastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993:250:11-7.
125. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996:200:135-41.
126. Farber LA, Benard F, Machtay M, et al. Detection of recurrent head and neck squamous cell carcinomas after radiation therapy with 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography. Laryngoscope 1999; 109:970-5.
127. Berlangieri SU, Brizel DM, Scher RL, et al. Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy. Head Neck 1994:16:340-6.
128. Shaha AR. Preoperative evaluation of the mandible in patients with carcinoma of the floor of the mouth. Head Neck 1991;!3:398-402.
129. Deleyiannis FW, Weymuller EA Jr. Garcia I, Potosky AL. Geographic variation in the utilization of esophagoscopy and bronchoscopy in head and neck cancer. Arch Otolaryngol Head Neck Surg 1997:123:1203-10.
130. Fijuth J. Mazeron JJ, Le Pechoux C, et al. Second head and neck cancers following radiation therapy of Tl and T2 cancers of the oral cavity and oropharynx. Int J Radiât Oncol Biol Phys 1992:24:59-64.
131. Larson JT, Adams GL, Fattah HA. Survival statistics for multiple primaries in head and neck cancer. Otolaryngol Head Neck Surg 1990:103:14-24.
132. Grossman TW, Kita MS. Toohill RJ. The diagnostic accuracy of pharyngoesophagram compared to esophagoscopy in patients with head and neck cancer. Laryngoscope 1987:97:1030-2.
133. Bacon CK, Hendrix RA. Open tube versus flexible esophagoscopy in adult head and neck endoscopy. Ann Otol Rhinol Laryngol 1992:101:147-55.
134. Marsh BR. Endoscopy of tracheobronchial tree and esophagus. In: Cummings CW, Fredrickson JM. Harker LA, Krause CJ. Schuller DE, editors. Otolaryngology: head and neck surgery. 2nd edition. St Louis: Mosby Year Book: 1993. p.2229-42.
135. Spiro RH, Strong EH. Epidermoid carcinoma of the mobile tongue treated by partial glossectomy alone. Am J Surg 1971:122:707-10.
136. O'Brien CJ. Lahr CJ, Soong S. Surgical treatment of early stage carcinoma of the oral tongue. Head Neck Surg 1986:8:401-8.
137. Shah JP. Lydiatt WM. Buccal mucosa. alveolus, retromolar trigone, floor of the mouth, hard palate, and tongue tumors. In: Thawley S, Panje WR, Batsakis J, Lindberg RD, editors. Comprehensive management of head and neck tumors. 2nd edition. Philadelphia: Saunders; 1999. p.686-94.
138. Effron MZ. Johnson JT. Myers EN, Curtin H, Beery Q, Sigler B. Advanced carcinoma of the tongue: management by total glossectomy without laryngectomy. Arch Otolaryngol 1981:107:694-7.
139. Myers EN. The role of total glossectomy in the management of cancer of the oral cavity. Otolaryngol Clin North Am 1972:5:343-55.
140. Pradhan SA, Rajpal RM. Total glossectomy sans laryngectomy: Are we justified? Laryngoscope 1983:93:813-5.
141. Weber RS, Ohlms L, Bowman J. Jacob R. Goepfert H. Functional results after total or near total glossectomy with laryngeal preservation. Arch Otolaryngol Head Neck Surg 1991:117:512-5.
142. Tiwari RM. Greven AJ, Karim AB, Snow GB. Total glossectomy: reconstruction and rehabilitation. J Laryngol Otol 1989;103:917-21.
143. Barttelbort SW, Ariyan S. Mandible preservation with oral cavity carcinoma: rim mandibulectomy versus sagittal mandibulectomy. Am J Surg 1993:166:411-5.
144. Byers RM, Weber RS, Andrews T, McGill D, Kare R, Wolf P. Frequency and therapeutic implications of "skip métastases" in the neck from squamous carcinoma of the oral tongue [see comments]. Head Neck 1997:19:14-9.
145. Johnson JT, Leipzig B, Cummings CW. Management of Tl carcinoma of anterior aspect of the tongue. Arch Otolaryngol Head Neck Surg 1980:106:249-51.
146. Byers RM, Wolf PF, Ballantyne AJ. Rationale for elective modified neck dissection. Head Neck Surg 1988:10:160-7.
147. Spiro JD, Spiro RH, Shah JP, Sessions R, Strong EW. Critical assessment of supraomohyoid neck dissection. Am J Surg 1988:156:286-9.
148. Byers RM, El Naggar AK, Lee YY. et al. Can we detect or predict the presence of occult nodal métastases in patients with squamous carcinoma of the oral tongue? Head Neck 1998;20:138-44.
149. Urken ML, Moscoso JF, Lawson W, Biller HF. A systematic approach to functional reconstruction of the oral cavity following partial and total glossectomy. Arch Otolaryngol Head Neck Surg 1994;120:589-601.
150. McConnel FM, Teichgraeber JF, Adler RK. A comparison of three methods of oral reconstruction. Arch Otolaryngoi Head Neck Surg 1987;! 13:496-500.
151. Kroll SS, Evans GR, Goldberg D, et al. A comparison of resource costs for head and neck reconstruction with free and pectoralis major flaps. Plast Reconstr Surg 1997:99:1282-6.
152. Kroll SS, Reece GP, Miller MJ, Schusterman MA. Comparison of the reclus abdominis free flap with the pectoralis major myocutaneous flap for reconstructions in the head and neck. Am J Surg 1992:164:615-8.
153. Lyos AT, Evans GR, Perez D, Schusterman MA. Tongue reconstruction: outcomes with the reclus abdominis flap. Plast Reconstr Surg 1999; 103:442-7.
154. Kroll SS. Schusterman MA, Reece GP. Cosls and complicalions in mandibular reconstruction. Ann Plast Surg 1992;29:341-7.
155. Ash CL. Oral cancer: a 25 year study. AJR Am J Roentgenol 1962;87:417-30.
156. Rudollz MS, Perkins RS, Luthmann RW, et al. High dose-rate brachylherapy for primary carcinomas of ihe oral cavily and oropharynx. Laryngoscope 1999; 109:1967-73.
157. Dearnaley DP, Dardoufas C, A'Hearn RP, Henk JM. Interstitial irradiation for carcinoma of the tongue and floor of the mouth: Royal Marsden Hospital experience 1970-1986. Radiolher Oncol 1991:21:183-92.
158. Delclos L, Lindberg RD, Flelcher GH. Squamous cell carcinoma of ihe oral tongue and floor of the mouth: evaluation of interstitial radium therapy. Am J Roentgenol 1976:126:223-8.
159. Practice Guidelines for Squamous Cell Cancers of the Head and Neck. Philadelphia: National Comprehensive Cancer Network; 2000.
160. Shah JP, Lydia WM. Buccal mucosa, alveolus, relromolar trigone, floor of Ihe mouih. hard palate, and tongue lumors. In: Thawley S. Panje WR, Batsakis J. Lindberg RD, editors. Comprehensive management of head and neck lumors. 2nd edilion. Philadelphia: Saunders; 1999. p.686-94.
161. Johnson JT, Wagner RL, Myers EN. A long-term assessment of adjuvant chemotherapy on oulcome of patients with extracapsular spread of cervical métastases from squamous carcinoma of the head and neck. Cancer 1996;77:181-5.
162. Lacy PD, Piccirillo JF, Merritt MG, Zequeir MR. Head and neck squamous cell carcinoma: better lo be young. Otolaryngol Head Neck Surg 2000; 122:253-8.
163. McGregor G. Davis N, Robins RE. Squamous cell carcinoma of the tongue and lower oral cavity in patienls less lhan 40 years of age. Am J Surg 1982;145:88-92.
164. Byers R. Squamous cell carcinoma of ihe oral tongue in patients less lhan 30 years of age. Am J Surg 1975:13:475-8.
165. Myers JN, Elkins T, Roberts D, Byers R. Squamous cell cancer of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 2000:122:44-51.
166. Friedlander PL, Schantz SP, Shaha AR, Yu G, Shah JP. Squamous cell carcinoma of the tongue in young patienls: a malched pair analysis. Head Neck 1997:20:363-8.
167. Siegelmann-Danieli N, Hanlon A, Ridge A, Padmore R, Fein DA, Langer CJ. Oral tongue cancer in patients less than 45 years old: institutional experience and comparison with older patients. J Clin Oncol 1998:16:745-53.
168. McGuirt WF Jr, Johnson JT. Myers EN. Rothfield R. Wagner R. Floor of the mouth carcinoma: the management of the clinically negative neck. Arch Otolaryngol Head NeckSurg 1995:121:278-82.
169. Shaha AR, Spiro RH, Shah JP, Strong EW. Squamous carcinoma of the floor of the mouth. Am J Surg 1984:148:455-9.
170. Mazeron JJ, Grimard L. Raynal M. et al. Iridium-192 curietherapy for Tl and T2 epidermoid carcinomas of the floor of the mouth. Int J Radial Oncol Biol Phys 1990:18:1299-306.
171. Mazeron JJ, Simon JM, Le Pechoux C, et al. Effect of dose rate on local control and complications in definitive irradiation of T1-2 squamous cell carcinomas of mobile tongue and floor of the mouth with interstitial iridium-192. Radiother Oncol 1991:21:39-47.
172. Baker SR. Malignant neoplasms of the oral cavity. In: Cummings CW, Fredrickson JM, Harker LA, Krause CJ. Schuller DE, editors. Otolarynoglogy: head and neck surgery. 2nd edition. St Louis: Mosby-Year Book: 1993. p. 1248-305.
173. Shumrick DA, Quenelle DJ. Malignant disease of the tonsillar region, retromolar trigone and buccal mucosa. Otolaryngol Clin North Am 1979:12:115-20.
174. Alvi A, Myers EN. Skin graft reconstruction of the composite resection defect. Head Neck 1996:18:538-43.
175. Backstrom A, Jakobsson P. Nathanson A. Wersall J. Prognosis of squamous-cell carcinoma of the gums with cytologically verified cervical lymph node métastases. J Laryngol Otol 1975:89:391-6.
176. Chung CK, Johns ME, Cantrell RW, Constable WC. Radiotherapy in the management of primary malignancies of the hard palate. Laryngoscope 1980:90:576-84.
177. Kornblith AB, Zlotolow IM. Gooen J. et al. Quality of life of maxillectomy patients using an obturator prosthesis. Head Neck 1996:18:323-34.
178. Le QT, Birdwell S, Terris DJ. et al. Postoperative irradiation of minor salivary gland malignancies of the head and neck. Radiother Oncol 1999:52:165-71.
179. Evans HL, Shah JP. Epidermoid carcinoma of the palate. Am J Surg 1981:142:451 -8.
180. Sankaranarayanan R. Oral cancer in India: an epidemiologic and clinical review. Oral Surg Oral Med Oral Pathol 1990:69:325-30.
181. Shear M, Pindborg JJ. Verrucous hyperplasia of the oral mucosa. Cancer 1980:46:1855-62.
182. Vegers JWM. Snow GB. Van der Waal I. Squamous cell carcinoma of the buccal mucosa. Arch Otolaryngol Head Neck Surg 1979:105:192-5.
183. Nair MK, Sankaranarayanan R, Padmanabhan TK. Evaluation of the role of radiotherapy in the management of carcinoma of the buccal mucosa. Cancer 1988; 61:1326-31.
184. Dhawan IK, Verma K. Khazanchi RK. Carcinoma of the buccal mucosa: incidence of regional lymph node involvement. Indian J Cancer 1993:30:176-80.
185. Close LG, Brown PM. Vuitch MF, Reisch J. Schaefer SD. Microvascular invasion and survival in cancer of the oral cavity and oropharynx. Arch Otolaryngol Head NeckSurg 1989:115:1304-9.
186. Dixit S, Vyas RK, Toparani RB, Baboo HA, Patel DD. Surgery versus surgery and postoperative radiotherapy in squamous cell carcinoma of the buccal mucosa: a comparative study. Ann Surg Oncol 1998:5:502-10.
187. Fang FM, Leung SW, Huang CC, et al. Combined-modality therapy for squamous carcinoma of the buccal mucosa: treatment results and prognostic factors. Head Neck 1997;19:506-12.
188. Urist MM, O'Brien CJ, Soong SJ, Visscher DW, Maddox WA. Squamous cell carcinoma of the buccal mucosa: analysis of prognostic factors. Am J Surg 1987:154:411-4.
189. Crue G. Excision of cancer of the head and neck with special reference to the plan of dissection based on 132 operations. JAMA 1906;47:1780-6.
190. Martin H. Val le BD. Ehrlich H, Cahan WG. Neck dissection. Cancer 1951:4:44199.
191. Bocca E, Pignataro O, Oldini C, Cappa C. Functional neck dissection: an evaluation and review of 843 cases. Laryngoscope 1984;94:942-5.
192. Suarez O. El Problema De Las Metastasis Linfaticas y Alejandas Del Cancer De Laringe e Hipofaringe. Rev Otorrinolaringol 1963;23:83-9.
193. Ballantyne AJ. Neck dissections for cancer. Curr Probl Cancer 1985:9:3-34.
194. Medina JE, Byers RM. Supraomohyoid neck dissection: rationale, indicators, and surgical technique. Head Neck 1989:11:111-22.
195. Andersen LJ. Therkildsen MH, Ockelmann HH, Bentzen JD, Schiodt T. Hansen HS. Malignant epithelial tumors in the minor salivary glands, the submandibular gland, and the sublingual gland: prognostic factors and treatment results. Cancer 1991:68:2431-7.
196. Khafif RA. Gelbfish GA, Asase DK, Tepper P, Attie JN. Modified radical neck dissection in cancer of the mouth, pharynx, and larynx. Head Neck 1990:12:476-82.
197. De Santo LW. Neck dissection: Is it worthwhile? Laryngoscope 1982:92:502-9.
198. Andersen PE, Shah JP, Cambroner E. Spiro, RH. The role of comprehensive neck dissection with preservation of the spinal accessory nerve in the clinically positive neck. Am J Surg 1994:168:499-502.
199. Byers RM, dayman GL, McGill D, et al. Selective neck dissections for squamous carcinoma of the upper aerodigestive tract: patterns of regional failure. Head Neck 1999:21:499-505.
200. Yuen AP, Wong YM, Tang KC. Elective neck dissection versus observation in the treatment of early oral tongue carcinoma. Head Neck 1997:19:583-8.
201. Haddadin KJ. Soutar DS, Oliver RJ, Webster MH, Robertson AG, MacDonald DG. Improved survival for patients with clinically T1/T2, NO tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999:21:517-25.
202. Jesse RH, Barkley HT Jr, Lindberg RD, Fletcher GH. Cancer of the oral cavity: Is elective neck dissection beneficial? Am J Surg 1970:120:505-8.
203. Lefebvre JL, Coche-Dequeant B, Buisset E, Mirabel X. Van JT, Prévost B. Management of early oral cavity cancer: experience of Centre Oscar Lambret. Eur J Cancer B Oral Oncol 1994;30B:216-20.
204. Kligerman J. Lima RA. Soares JR, et al. Supraomohyoid neck dissection in the treatment of TI/T2 squamous cell carcinoma of oral cavity. Am J Surg 1994:168:391-4.
205. Shah JP. Candela FC, Poddar AK. The patterns of cervical lymph node métastases from squamous carcinoma of the oral cavity. Cancer 1990:66:109-13.
206. Brazilian Head and Neck Cancer Study Group. Results of a prospective trial on elective modified radical classical vs supraomohyoid neck dissection in the management of oral squamous carcinoma. Am J Surg 1998:176:422-7.
207. Henick DH, Silver CE, Heller KS, Shaha AR. El GH. Wo Ik DP. Supraomohyoid neck dissection as a staging procedure for squamous cell carcinomas of the oral cavity and oropharynx. Head Neck 1995:17:1 19-23.
208. Ambrosch P, Freudenberg I, Krön M, Steiner W. Selective neck dissection in the management of squamous cell carcinoma of the upper digestive tract. Eur Arch Otorhinolaryngol 1996:253:329-53.
209. Pitman KT. Johnson JT, Myers EN. Effectiveness of selective neck dissection for management of the clinically negative neck. Arch Otolarvngol Head Neck Surg 1997:123:917-22.
210. Kerrebijn J. Freeman J. Irish JC. et al. Supraomohyoid neck dissection: Is it diagnostic or therapeutic? Head Neck 1999:21:39-42.
211. van den Brekel MW, Stel HV, Castelijns JA. Groll GJ. Snow GB. Eymph node staging in patients with clinically negative neck examinations by ultrasound and ultrasound-guided aspiration cytology. Am J Surg 1991:162:362-6.
212. Adams S. Baum RP, Stuckensen T, Bitter K, Hör G. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT. MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998;25:1255-60.
213. Myers LL. Wax MK. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer. J Otolaryngol 1998:27:342-7.
214. Braams JW, Pruim J. Freling NJ. et al. Detection of lymph node métastases ofsquamous-cell cancer of the head and neck with FDG-PET and MRI. J Nucl Med 1995:36:211-6.
215. Braams JW, Pruim J, Nikkels PG, Roodenburg JL. Vaalburg W, Vermey A. Nodal spread of squamous cell carcinoma of the oral cavity detected with PET-tyrosine. MRI and CT. J Nucl Med 1996:37:897-901.
216. Munro AJ. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer [see comments]. Br J Cancer 1995:71:83-91.
217. Pignon JP. Bourhis J, Domenge C, Désigne L. Chemotherapy added to locoregional treatment for head and neck squamous- ell carcinoma: three meta-analyses of updated individual data: MACH-NC Collaborative Group: meta-analysis of chemotherapy on head and neck cancer [in process citation]. Lancet 2000:355:949-55.
218. Yokes EE, Kies MS. Haraf DJ. et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 2000;18:1652-61.
219. Robbins KT. Kumar P. Régine WF, et al. Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int J Radiât Oncol Biol Phys 1997:38:263-71.
220. Kerber CW, Wong WH. Howell SB, Hanchett K, Robbins KT. An organ-preserving selective arterial chemotherapy strategy for head and neck cancer. AJNR Am J Neuroradiol. 1998:19:935-41.
221. Painter C. Physiology. In: Cummings CW, Fredrickson JM. Harker LA, Krause CJ, Schuller DE, editors. Otolaryngology: Head and neck surgery. 2nd edition. St Louis: Mosby-Year Book: 1993. p. 1704-48.
222. Pauloski BR, Rademaker AW. Logemann JA, Colangelo LA. Speech and swallowing in irradiated and nonirradiated postsurgical oral cancer patients. Otolaryngol Head Neck Surg 1998:118:616-24.
223. Teichgraeber J, Bowman J, Goepfert H. Functional analysis of treatment of oral cavity cancer. Arch Otolaryngol Head Neck Surg 1986:112:959-65.
224. Colangelo LA, Logemann JA. Pauloski BR, Pelzer HJ, Rademaker AW. T stage and functional outcome in oral and oropharyngeal cancer patients. Head Neck 1996; 18:259-68.
225. Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA. Speech and swallowing rehabilitation for head and neck cancer patients. Oncology 1997;! 1:651-64.
226. Schliephake H, Schmelzeisen R, Schonweiler R. Schneller T, Altenbernd C. Speech, deglutition and life quality after intraoral tumour resection: a prospective study. Int J Oral Maxillofac Surg 1998:27:99-105.
227. Lucente FE. Diktaban T. Lawson W, Biller HF. Chyle fistula management. Otolaryngol Head Neck Surg 1981:89:575-8.
228. de Gier HH, Balm AJ, Bruning PF, Gregor RT, Hilgers FJ. Systematic approach to the treatment of chylous leakage after neck dissection. Head Neck 1996:18:347-51.
229. Myers EN. Dinerman WS. Management of chylous fistulas. Laryngoscope 1975:85:835-40.
230. Grandis JR, Vickers RM. Rihs JD, Yu VL, Johnson JT. Efficacy of topical amoxicillin plus clavulanate/ticarcillin plus clavulanate and clindamycin in contaminated head and neck surgery: effect of antibiotic spectra and duration of therapy. J Infect Dis 1994:170:729-32.
231. Grandis JR, Vickers RM. Rihs JD, et al. The efficacy of topical antibiotic prophylaxis for contaminated head and neck surgery. Laryngoscope 1994:104:719-24.
232. Robbins KT, Byers RM, Cole R, et al. Wound prophylaxis with metronidazole in head and neck surgical oncology. Laryngoscope 1988:98:803-6.
233. Weber RS. Raad I, Frankenthaler R, et al. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery: the need for Gram-negative coverage. Arch Oiolaryngol Head Neck Surg 1992:118:1159-63.
234. Johnson JT, Ferretti GA, Nethery WJ, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993;329:390-5.
235. Larson DL, Lindberg RD. Lane E, Goepfert H. Major complications of radiotherapy in cancer of the oral cavity and oropharynx: a 10 year retrospective study. Am J Surg 1983:146:531-6.
236. Pyykonen H, Malmstrom M, Oikarinen VJ, Salmo M, Vehkalahti M. Late effects of radiation treatment of tongue and floor-of-mouth cancer on the dentition, saliva secretion, mucous membranes and the lower jaw. Int J Oral Maxillofac Surg 1986:15:401-9.
237. Glanzmann C, Gratz KW. Radionecrosis of the mandibula: a retrospective analysis of the incidence and risk factors. Radiother Oncol 1995:36:94-100.
238. Morrish RB Jr, Chan E, Silverman S Jr. Meyer J, Fu KK, Greenspan D. Osteonecrosis in patients irradiated for head and neck carcinoma. Cancer 1981:47:1980-3.
239. Mainous EG, Hart GB. Osteoradionecrosis of the mandible: treatment with hyperbaric oxygen. Arch Otolaryngol 1975:101:173-7.